IN8bio, Inc.
IN8bio, Inc.（INAB）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
inab · 股价预测 · 4 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 4 位华尔街分析师
Buy
4 位分析师
共识
评级分布
12 个月目标价
High
$4.00
Consensus
$4.00
+177.8% upside
Low
$4.00
Median: $4 · Last Close: $1.44
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.39 | ↓ 3.73% |
1-day model range: $1.36–$1.41. Peak: $1.41 (-3.73%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · INAB · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-11 | Jones Trading | Upgrade ↑ | Hold→Buy |
| 2024-11-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-12 | Jones Trading | Downgrade ↓ | Buy→Hold |
| 2024-06-14 | Jones Trading | Maintains | Buy→Buy |
| 2024-06-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-06-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on IN8bio, Inc. (INAB) stock. Of the recent 20 rating actions, 1 were upgrades and 2 were downgrades. 4 analysts currently cover INAB.
分析师推荐趋势
INAB analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$48M
↑ 338.0% YoY
Revenue Next Year
$1M
↓ 97.7% YoY
EPS This Year
$-1.24
EPS Next Year
$-1.06
↓ 14.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast INAB EPS of $-1.24 for the current fiscal year, based on estimates from 3 analysts. The INAB revenue forecast is $48M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
INAB 股价预测由两类独立数据源支撑：来自 4 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。INAB 的共识目标价为 $4.00（+177.8% 上行空间），分析师共识为 Buy。
INAB 的短期预测（明日）为 $1.39（-3.73%）。 INAB 对 2030 年的预测区间为 $0–$0。
IN8bio, Inc. 在 NASDAQ 上市，代码 INAB。INAB 在 2027 年的整体展望偏积极，在覆盖分析师中约 75% 对应 Buy 共识。
常见问题
INAB 预测 · 8 个问题根据 4 位华尔街分析师，INAB 的 12 个月平均目标价为 $4.00，最高 $4.00、最低 $4.00。若有图表，中位目标价可在上方查看。相对当前价 $1.44，隐含约 +177.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.